CENTURY THERAPEUTICS INC (IPSC)

US15673T1007 - Common Stock

3.01  -0.12 (-3.83%)

After market: 3.07 +0.06 (+1.99%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-3-31)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income
-133.48M-136.67M-130.93M-95.82M-53.58M
Depreciation Amortization
13.36M13.04M8.44M3.75M1.40M
Change In Working Capital
4.31M9.16M123.44M-3.58M6.37M
Interest Paid
236.00K586.00K1.10M970.00KN/A
Other non cash items
26.41M26.12M13.10M6.66M4.54M
OPERATING CASH FLOW
-89.38M-88.35M14.05M-89.00M-41.27M
 
CASH FLOWS FROM INVESTING ACTIVITIES
Capital Expenditure
-9.29M-13.74M-30.60M-44.97M-14.55M
Other Investing Activity
50.62M74.87M17.48M-253.37M-8.21M
INVESTING CASH FLOW
41.33M61.13M-13.13M-298.34M-22.76M
 
CASH FLOWS FROM FINANCING ACTIVITIES
Debt Issued/Reduced
N/A-10.24MN/A0.009.73M
Stock Issued/Repurchased
18.26M516.00K27.16M383.55M0.00
Other Financing Activity
N/AN/A0.0034.23M37.96M
FINANCING CASH FLOW
8.02M-9.72M27.16M417.77M47.69M
 
CHANGE IN CASH
-40.02M-36.94M28.08M30.43M-16.34M
 
FREE CASH FLOW
Operating Cash Flow
-89.38M-88.35M14.05M-89.00M-41.27M
Capital Expenditure
-9.29M-13.74M-30.60M-44.97M-14.55M
FREE CASH FLOW
-98.66M-102.08M-16.55M-133.97M-55.82M

All data in USD

Charts